Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis
- PMID: 25366383
- DOI: 10.1007/s11739-014-1144-x
Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis
Abstract
Ulcerative colitis (UC) is a chronic, idiopathic, inflammatory large bowel disease with recurrent variable periods of exacerbation. The aim of the current study is to evaluate the correlation of UCEIS with fecal calprotectin (FC) level to assess disease activity in UC patients in order to determine whether FC can prognosticate clinical outcome and disease activity of UC instead of colonoscopic evaluation. Our endoscopic investigations revealed the extension of UC as the following: proctitis (11.6%), procto-sigmoiditis (18.5%), left-sided colitis (15.8%), extensive colitis (11.7%), and normal endoscopy (42.4%). Conclusively, we suggest that FC can be used as a reliable tool to evaluate disease activity in ulcerative colitis patients. Moreover, our findings indicate a significant correlation between FC level and mucosal healing.
Similar articles
-
Fecal calprotectin predicts complete mucosal healing and better correlates with the ulcerative colitis endoscopic index of severity than with the Mayo endoscopic subscore in patients with ulcerative colitis.BMC Gastroenterol. 2017 Oct 23;17(1):110. doi: 10.1186/s12876-017-0669-7. BMC Gastroenterol. 2017. PMID: 29061121 Free PMC article.
-
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.Clin Gastroenterol Hepatol. 2015 Nov;13(11):1929-36.e1. doi: 10.1016/j.cgh.2015.05.038. Epub 2015 Jun 4. Clin Gastroenterol Hepatol. 2015. PMID: 26051392
-
Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.Digestion. 2018;97(1):82-89. doi: 10.1159/000484223. Epub 2018 Feb 1. Digestion. 2018. PMID: 29393146
-
From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting.World J Gastroenterol. 2018 Sep 7;24(33):3681-3694. doi: 10.3748/wjg.v24.i33.3681. World J Gastroenterol. 2018. PMID: 30197475 Free PMC article. Review.
-
Evaluation of Mucosal Healing in Ulcerative Colitis by Fecal Calprotectin vs. Fecal Immunochemical Test: A Systematic Review and Meta-analysis.Turk J Gastroenterol. 2023 Sep;34(9):892-901. doi: 10.5152/tjg.2023.22812. Turk J Gastroenterol. 2023. PMID: 37427885 Free PMC article.
Cited by
-
Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study.Intest Res. 2018 Oct;16(4):554-562. doi: 10.5217/ir.2018.00027. Epub 2018 Oct 10. Intest Res. 2018. PMID: 30301337 Free PMC article.
-
Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.Med Arch. 2024;78(2):105-111. doi: 10.5455/medarh.2024.78.105-111. Med Arch. 2024. PMID: 38566874 Free PMC article.
-
Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission.Medicina (Kaunas). 2020 Dec 31;57(1):31. doi: 10.3390/medicina57010031. Medicina (Kaunas). 2020. PMID: 33396524 Free PMC article.
-
Fecal calprotectin: its scope and utility in the management of inflammatory bowel disease.J Gastroenterol. 2016 May;51(5):434-46. doi: 10.1007/s00535-016-1182-4. Epub 2016 Feb 20. J Gastroenterol. 2016. PMID: 26897740 Review.
-
Correlation between Clinical Symptoms and Lab Tests with Endoscopic Severity Indexes in Patients with Inflammatory Bowel Diseases.Middle East J Dig Dis. 2020 Jul;12(3):162-170. doi: 10.34172/mejdd.2020.178. Middle East J Dig Dis. 2020. PMID: 33062221 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical